| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07436858 Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab… |
date change Primary completion pushed: 2030-06-01 -> 2030-07-07 |
| 2026-08-12 | NCT07436858 Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab… |
date change Completion pushed: 2030-06-01 -> 2030-07-07 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06875258 | PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for… | Erectile Dysfunction Following Radical Prostatectomy | Recruiting |
| Phase 3 | |||
| NCT06857773 | Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined… | Colorectal Neoplasms | Recruiting |
| NCT07281508 | Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial | Cisplatin-related Hearing Loss | Recruiting |
| NCT06888817 | Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic… | Radiation Necrosis | Recruiting |
| NCT01646034 | High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast… | Breast Cancer | Active, Not Recruiting |
| NCT04949113 | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic… | Malignant Melanoma Stage III | Active, Not Recruiting |
| NCT01996267 | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 | Breast Cancer | Active, Not Recruiting |
| NCT03348150 | Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal… | Stomach Neoplasm | Active, Not Recruiting |
| NCT07486687 | Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With… | Triple Negative Breast Cancer (TNBC), Early Setting | Not Yet Recruiting |
| NCT03772028 | Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy… | Ovarian Cancer | Active, Not Recruiting |
| NCT02810743 | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer | Breast Cancer | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06855095 | Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting… | Neuroendocrine Tumors | Recruiting |
| NCT07310758 | Contrast-enhanced Ultrasound for Sentinel Node Detection | Melanoma | Recruiting |
| NCT06279130 | Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel… | Resectable MMR-deficient Solid Tumors | Recruiting |
| NCT01057069 | Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer | Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT04159818 | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple… | Metastatic Breast Cancer | Recruiting |
| NCT04161664 | Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy | Metastatic Squamous Cell Carcinoma of the Vulva | Recruiting |
| NCT04192253 | Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin… | Locally Advanced, Squamous Cell Carcinoma of the Vulva | Recruiting |
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | Cancer | Recruiting |
| NCT05905315 | Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment… | Locally Advanced Vulvar Carcinoma | Recruiting |
| NCT03815890 | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | Breast Cancer | Recruiting |
| NCT06342037 | NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC)… | Metastatic Breast Cancer | Recruiting |
| NCT05301881 | COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in… | Breast Cancer Invasive | Recruiting |
| NCT06823479 | Towards Cure Via Only Ultra-short ICB in CSCC | Cutaneous Squamous Cell Carcinoma (CSCC) | Recruiting |
| NCT05982678 | Basket Study for Oligo-metastatic Breast Cancer | HER2-positive Breast Cancer | Recruiting |